In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...

The FDA has approved biosimilars for: While many psoriasis medications come as injections, apremilast is a psoriasis treatment that comes as a pill. If you can’t take any of these medications or ...

Medically reviewed by William Truswell, MD Psoriasis is a chronic skin condition with many options to help manage your ...

Teva Pharmaceuticals (TEVA) and Alvotech (ALVO) announced the availability of SELARSDI injection in the U.S., a biosimilar to Stelara for the ...

Some studies have found it to be more effective than other biologic drugs prescribed to treat psoriasis. Biologics are a class of drugs usually administered by injection. These drugs alter the ...

Psoriasis treatments come in different forms ... The downside is that you’ll either have to visit an infusion center or get an injection. If you’re not a fan of needles, biologics may not ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

Injections should not be administered into psoriasis skin lesions. Signs and symptoms of infection should be reviewed with the patient. Make sure patients understand that an ISR will resolve and ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...